Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Thomas Duke Urice , MD

Specialist • Norman, OK

Active NPI 1023016169 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

2413 Palmer Cir
Norman, OK 730696301

Call 4053215322 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

2413 Palmer Cir

Norman, OK 730696301

Telephone 4053215322
Fax 4053215348
Organization at the Same NPPES Address or Phone
Paul S. Gillum, Md, Pc Facility NPI 1407024367

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File

Medical School

University Of Oklahoma College Of Medicine

Graduation Year

1978

Medicare patients

2,509 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $548,372 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $354,098 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

3,113 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$801,459 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $1,759.52 across 84 records.

By nature of payment

  • Food and Beverage: $1,659.53 across 83 records.
  • Education: $99.99 across 1 record.

Reporting-company totals (3 largest of 17)

  • Regeneron Pharmaceuticals, Inc.: $361.76 across 11 records.
  • Sanofi and Genzyme US Companies: $334.71 across 15 records.
  • Janssen Pharmaceuticals, Inc: $302.06 across 9 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

48 years (graduated 1978)

CMS Doctors and Clinicians data list 1978 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File.

NPI first issued

2005

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Urice has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Urice as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Norman and Oklahoma

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 90% of clinicians listed under Specialist in Oklahoma (2024, 51 clinicians with data). Median for this group: 811. Middle half: 290 to 3,739.

Too few clinicians listed under Specialist in Norman have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A higher Medicare-allowed amount than 90% of clinicians listed under Specialist in Oklahoma (2024, 51 clinicians with data). Median for this group: $94,041. Middle half: $22,116 to $202,129.

Too few clinicians listed under Specialist in Norman have Medicare Part B data for 2024 to compare.

Paid by Medicare

A higher Medicare payment amount than 90% of clinicians listed under Specialist in Oklahoma (2024, 51 clinicians with data). Median for this group: $72,127. Middle half: $16,619 to $148,681.

Too few clinicians listed under Specialist in Norman have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

More Part D prescriptions than 65% of clinicians listed under Specialist in Oklahoma (2024, 52 clinicians with data). Median for this group: 601. Middle half: 142 to 3,273.

Too few clinicians listed under Specialist in Norman have Medicare Part D data for 2024 to compare.

Part D drug cost

A higher Part D drug cost than 85% of clinicians listed under Specialist in Oklahoma (2024, 52 clinicians with data). Median for this group: $24,288. Middle half: $3,953 to $496,912.

Too few clinicians listed under Specialist in Norman have Medicare Part D data for 2024 to compare.

22 active clinicians are listed under Specialist with a practice address in Norman, OK (425 in Oklahoma).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Norman

4.5% of these 22 clinicians have the CMS telehealth indicator.

31.8% of these 22 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 84 records totaling $1,759.52.

Manufacturer Payment Nature Product Type Amount ($)
Janssen Pharmaceuticals, Inc
Education
In-kind items and services
TREMFYA General $99.99
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $39.74
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $38.77
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $37.18
Pfizer Inc.
Food and Beverage
In-kind items and services
LITFULO General $36.83
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $36.60
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $35.00
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $34.99
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $32.64
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $30.51
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $29.21
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $29.21
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $29.21
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $29.21
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $28.82
Regeneron Pharmaceuticals, Inc.
Food and Beverage
In-kind items and services
DUPIXENT General $28.82
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $28.70
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $28.40
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $27.85
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $27.82
Biocon Biologics Inc
Food and Beverage
In-kind items and services
Yesintek General $26.51
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
Rhapsido General $26.43
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $26.30
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $26.10
Sanofi and Genzyme US Companies
Food and Beverage
In-kind items and services
DUPIXENT General $25.86

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
2,676 1,911 $84.91 $77.64
17003 Destruction of precancer skin growth, 2-14 growths
2,161 503 $6.11 $5.53
17000 Destruction of precancer skin growth, 1 growth
1,214 807 $62.23 $44.94
17110 Destruction of skin growth, 1-14 growths
1,095 904 $104.10 $92.62
11102 Biopsy of related skin growth, first growth
708 576 $91.72 $73.95
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
658 550 $52.25 $47.90
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
186 128 $121.59 $109.34
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
142 142 $103.91 $95.60
11103 Biopsy of related skin growth, each additional growth
95 83 $46.43 $41.87
10040 Acne surgery
82 76 $105.11 $96.84
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
74 72 $135.61 $118.04
17280 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less
69 62 $128.02 $114.92
17281 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
57 57 $165.75 $147.31
99202 New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
49 49 $70.01 $62.18
17260 Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less
41 32 $90.99 $73.13
17271 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
27 27 $151.55 $136.39
17111 Destruction of skin growth, 15 or more growths
22 20 $126.22 $113.20
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
15 15 $168.19 $148.95
17270 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less
15 15 $136.38 $125.05
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
11 11 $155.13 $144.14

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Triamcinolone Acetonide Triamcinolone Acetonide 401 12,486 $2,944.78 283
Hydrocortisone Hydrocortisone 276 7,471 $3,307.14 195
Clobetasol Propionate Clobetasol Propionate 214 5,994 $8,529.73 138
Doxycycline Hyclate Doxycycline Hyclate 206 9,608 $4,715.05 87
Metronidazole Metronidazole 185 5,850 $9,470.70 101
Hydroxyzine Hcl Hydroxyzine Hcl 131 5,148 $2,900.81 55
Minoxidil Minoxidil 115 7,446 $550.71 32
Dutasteride Dutasteride 100 7,480 $2,831.28 30
Clindamycin Phosphate Clindamycin Phosphate 60 2,214 $1,761.53 38
Valacyclovir Valacyclovir Hcl 51 610 $850.70 30
Dupixent Syringe Dupilumab 48 1,302 $188,015.70 —
Dupixent Pen Dupilumab 48 1,330 $192,172.24 —
Mupirocin Mupirocin 46 638 $298.74 41
Fluocinonide Fluocinonide 43 1,229 $1,582.26 37
Tretinoin Tretinoin 43 2,161 $3,375.26 24
Minocycline Hcl Minocycline Hcl 40 1,334 $575.11 11
Fluorouracil Fluorouracil 39 1,151 $2,548.24 36
Prednisone Prednisone 35 294 $79.56 30
Fluocinolone Acetonide Fluocinolone Acetonide 34 1,335 $1,277.47 23
Nystatin Nystatin 32 886 $774.78 14
Ciclopirox Ciclopirox 24 688 $460.10 14
Desonide Desonide 22 632 $2,081.49 13
Otezla Apremilast 22 660 $106,017.63 —
Tacrolimus Tacrolimus 21 555 $3,199.00 11
Terbinafine Hcl Terbinafine Hcl 19 1,318 $402.33 19

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Specialist Primary Specialty

NUCC Taxonomy Code: 174400000X

License # reported to NPPES OK 13255

An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Oklahoma State Board of Medical Licensure.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20080815000125

Enrollment State Jurisdiction

OK

PECOS Control ID

9830264589

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

2 listed
Dr. Paul Gillum , MD

Dermatology - Dermatopathology

NPI 1982602025

Doctor of Medicine (M.D.)

NPI 1871799619

Doctor of Medicine (M.D.)

Career & Practice History

NPI enumerated July 12, 2005.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.

No reviews have been published yet. Leave a review.